-
A new drug, pirfenidone, will be on the market soon
Time of Update: 2014-02-10
In 2006, the clinical study of pirfenidone was organized by union hospital In 2010, pirfenidone passed the new drug review In September 2011, it obtained the class 1.1 new drug certificate issued by t
-
In 2014, leading domestic generic pharmaceutical companies accelerated "counter attack"
Time of Update: 2014-01-29
At the beginning of this year, the news of Pfizer's divestiture of its generic pharmaceutical business was once again rampant According to foreign media, three pharmaceutical companies have expressed
-
Changchun Jinsai Pharmaceutical Co., Ltd. obtained the first production approval of biological preparation in 2014
Time of Update: 2014-01-17
Human growth hormone is mainly used in the treatment of dwarfism Research shows that about 2 / 3 of dwarfism is caused by heredity and puberty retardation, and 1 / 3 of pathological dwarfism is caused
-
Abiolone acetate, a prostate cancer treatment drug, has entered the first imitation competition mode
Time of Update: 2014-01-15
Abytiga acetate was originally developed by BTG company in the UK, and Johnson & Johnson obtained the development license In April 2011, the US FDA approved the drug for prostate cancer treatment by p
-
The first pharmacokinetic research platform in China is put into use to help a class of new drugs
Time of Update: 2014-01-12
How are drugs absorbed, distributed and excreted in the human body? "Drug transporter" is a small "Porter" who helps the process "Drug transporter is a series of proteins existing on the surface of ce
-
"Oral Recombinant Helicobacter pylori vaccine" won the second prize of 2013 national technological invention
Time of Update: 2014-01-10
Experts from the Third Military Medical University showed "oral Recombinant Helicobacter pylori vaccine" Reporter Li Wenke's "oral Recombinant Helicobacter pylori vaccine" won the second prize of 2013
-
Qizheng Tibetan medicine: promoting phase II clinical work of new anticancer drug ethane Selene
Time of Update: 2014-01-04
Qizheng Tibetan medicine said that recent rumors about the company's new anti-cancer drugs are inconsistent with the facts At present, the company and Peking University are promoting phase II clinical
-
Jindawei group plans to invest in antineoplastic new drug of Guoding Biotechnology
Time of Update: 2013-12-31
This investment is subject to the approval of the competent authorities on both sides of the Straits After the completion of the transaction, jindawei will hold no more than 5.17% of Guoding biotechno
-
Chongqing re creates 2.2 billion new class I drugs to realize technology transfer abroad
Time of Update: 2013-12-27
Yesterday, Chongqing Science and Technology Commission introduced that the transfer created two firsts, which is the first time for Chongqing pharmaceutical enterprises to realize the transfer of fore
-
Chengdu Baiyu new drug ginkgolide injection production project officially opened
Time of Update: 2013-12-27
In 2013, Sun Yi, chairman and President of Chengdu Baiyu group, had a really good life Since the company's innovative drug ginkgolide injection, which has been independently researched and developed f
-
Phase II clinical trial of antineoplastic new drug of Guoding Biotechnology
Time of Update: 2013-12-12
From left, Liu Shengyong, President of Guoding biotechnology, Wang Jinping, President of Taiwan Legislative Yuan, and Wu Liyu, President of Guoding biotechnology, recently attended few public events,
-
Research and development mode and status of Chinese new drugs
Time of Update: 2013-12-09
1 Analysis of all levels of China's pharmaceutical R & D forces at present, China's new pharmaceutical R & D forces include: national research institutes, private R & D institutions, "turtle" team, cr
-
Analysis of advantages and disadvantages of Chinese pharmaceutical cro industry
Time of Update: 2013-12-07
Analysis of the disadvantages of cro industry in China there are many problems in China's pharmaceutical cro industry, some of which are related to the development stage, some of which are related to
-
Agilent and Yuntai group are committed to developing molecular diagnosis and treatment products for blood diseases and cancer
Time of Update: 2013-12-07
The bio industry is one of the seven strategic emerging industries determined by the Chinese government, and the bio pharmaceutical industry ranks first in the bio industry According to the prediction
-
Roche and Geli work together to customize innovative hepatitis C drug danoprevir for Chinese patients
Time of Update: 2013-04-16
At present, there are about 10 million patients with chronic hepatitis C in China, most of them are 1b type Patients with this genotype have been shown to have a high response rate to danoprevier Ther
